mFOLFOX6 + BIBF 1120
TRICC-C (AIO-KRK-0111)
Phase 2 small_molecule completed
Quick answer
mFOLFOX6 + BIBF 1120 for Colorectal Cancer is a Phase 2 program (small_molecule) at Galmed Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Galmed Pharmaceuticals
- Indication
- Colorectal Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed